Remove Definition Remove Disease Remove Imaging Remove PET Scan
article thumbnail

PET Scans Reveal ‘smoldering’ Inflammation in patients with Multiple sclerosis

Imaging Technology

The team has worked for the past eight years on developing an approach of imaging cells called microglia. Microglia are immune cells in the brain that are thought to have a role in MS disease progression but cannot be seen by a routine MRI. The team developed a technique called F18 PBR 06 PET imaging.

article thumbnail

AI spots unidentified brain tumor on PET imaging

AuntMinnie

An AI algorithm designed for brain PET imaging found a glioblastoma in a patient that had gone undetected by physicians, according to a case reported February 15 in the Journal of Nuclear Medicine. Baseline scan (A), segmentation results (B), and follow-up scan (C) from patient with molecular glioblastoma.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Can PET help diagnose neurosarcoidosis?

AuntMinnie

FDG-PET imaging shows promise for use as a diagnostic criterion for neurosarcoidosis, with a recent case series illustrating the approach was effective when gold-standard approaches were not, according to a group of researchers in Berlin. “To In all three cases, gadolinium-enhanced MRI scans did not show abnormalities.

Diagnose 108
article thumbnail

Researchers offer hypothesis for long COVID brain fog

AuntMinnie

A group in France has offered an explanation for long COVID brain fog, with the concept based on a visual brain pattern they discovered on patient PET scans, according to a study published October 13 in Medical Hypotheses. “We A) PET scan of a healthy subject. (B) B) PET scan of a long COVID patient.

PET Scan 145
article thumbnail

Top Imaging News of 2023

Vesta Teleradiology

As we bid adieu to the final moments of 2023, it’s a great time to reflect on advancements and studies that have redefined the world of imaging this year. In this article, we’ll delve into the hottest news and breakthroughs in imaging, highlighting the remarkable strides that have made the headlines.

Imaging 52
article thumbnail

U.S. FDA Approves Blue Earth Diagnostics’ POSLUMA (Flotufolastat F 18) Injection, First Radiohybrid PSMA-targeted PET Imaging Agent for Prostate Cancer

Imaging Technology

Food and Drug Administration (FDA) approval for its optimized, high-affinity radiohybrid (rh) Prostate-Specific Membrane Antigen (PSMA)-targeted PET imaging agent, POSLUMA (flotufolastat F 18) injection (formerly referred to as 18F-rhPSMA-7.3 ). manufacturer and distributor, PETNET Solutions Inc, A Siemens Healthineers Company.

article thumbnail

The rise of theranostics: Part 4 -- Women's theranostics on the horizon

AuntMinnie

Theranostics is increasingly being used to image and treat prostate cancer and neuroendocrine tumors. Several presenters at the Society for Nuclear Medicine and Molecular Imaging's (SNMMI) 2024 meeting in Toronto shared new findings in women's studies. Women's theranostics appears to already be on the horizon.

Disease 105